| Literature DB >> 30637034 |
Inas R Ibrahim1, Subish Palaian2, Mohamed I Ibrahim3.
Abstract
BACKGROUND: Because community pharmacists are the most accessible healthcare professionals, they are often involved in managing minor ailments within the community setting.Entities:
Keywords: Community Pharmacy Services; Counseling; Diarrhea; Iraq; Nonprescription Drugs; Patient Simulation; Pharmacies; Professional Practice
Year: 2018 PMID: 30637034 PMCID: PMC6322980 DOI: 10.18549/PharmPract.2018.04.1313
Source DB: PubMed Journal: Pharm Pract (Granada) ISSN: 1885-642X
Diarrhea history taking practices of the community pharmacists
| Items of history taken | Male n (%) | Female n (%) | p-value (Chi-square) |
|---|---|---|---|
| 1. Duration of diarrhea | 0.004 | ||
| Yes | 28 (37.3) | 31 (41.3) | |
| No | 14 (18.7) | 2 (2.7)[ | |
| 2. Number of watery stool/day | 0.021 | ||
| Yes | 31 (41.3) | 31 (41.3) | |
| No | 11 (14.3) | 2 (2.7) a | |
| 3. Presence of blood in the stool | 0.000 | ||
| Yes | 8 (10.7) | 24 (32.0) | |
| No | 34 (45.3) | 9 (12.0) | |
| 4. Presence and number of vomiting | 0.404 | ||
| Yes | 27 (36.0) | 23 (30.7) | |
| No | 15 (20.0) | 10 (13.3) | |
| 5. Presence of fever, cough, or other problems | 0.000 | ||
| Yes | 8 (10.7) | 27 (36.0) | |
| No | 34 (45.3) | 6 (8.0) | |
| 6. Pre-illness practice | 0.253 | ||
| Yes | 25 (33.3) | 23 (30.7) | |
| No | 17 (22.7) | 10 (13.3) | |
| 7. Amount of fluid taken | 0.535 | ||
| Yes | 30 (40.0) | 23 (30.7) | |
| No | 12 (16.0) | 10 (13.3) | |
| 8. Presence of diseases and drug taken | 0.002 | ||
| Yes | 27 (36.0) | 31 (41.3) | |
| No | 15 (20.0) | 2 (2.7)[ |
Fisher’s Exact Test.
Medicines dispensed to the simulated patient
| Medicines (Generic name) | Pharmacological use | Pharmacies n (%) | Medicines Dispensed n (%) |
|---|---|---|---|
| Diphenoxylate HCL 2.5 + Atropine Sulphate 0.025mg | Antidiarrheal | 20 (26.8) | 20 (16.5) |
| Loperamide 2mg + Paracetamol | Antimotility + Antipyretic | 9 (12.0) | 18 (14.9) |
| Loperamide 2mg | Antimotility | 7 (9.3) | 7 (5.8) |
| (Diphenoxylate HCL 2.5 + Atropine Sulphate 0.025mg) + Hyoscine-N-ButylBromide 10mg | Antidiarrheal + Antispasmodic | 6 (8.0) | 12 (9.9) |
| (Diphenoxylate HCL 2.5 + Atropine Sulphate 0.025mg) + Paracetamol | Antidiarrheal + Antipyretic | 5 (6.7) | 10 (8.2) |
| Metronidazole 200mg | Antimicrobial | 4 (5.3) | 4 (3.3) |
| Loperamide 2mg + Hyoscine-N-ButylBromide 10mg | Antimotility + Antispasmodic | 4 (5.3) | 8 (6.6) |
| Furazolidone 50mg | Antimicrobial | 3 (4.0) | 3 (2.4) |
| Loperamide 2mg + Domperidone 10mg | Antimotility + Antidopaminergic/Antiemetic | 2 (2.7) | 4 (3.3) |
| Metronidazole 200mg + Domperidone 10mg | Antimicrobial + Antidopaminergic/Antiemetic | 2 (2.7) | 4 (3.3) |
| Metronidazole 200mg + Hyoscine-N-ButylBromide 10mg | Antimicrobial + Antispasmodic | 2 (2.7) | 4 (3.3) |
| Furazolidone 50mg + Paracetamol | Antimicrobial + Antipyretic | 2 (2.7) | 4 (3.3) |
| Loperamide 2mg + Hyoscine-N-ButylBromide 10mg + Paracetamol | Antimotility + Antispasmodic +Antipyretic | 2 (2.7) | 6 (4.6) |
| Hyoscine-N-ButylBromide 10mg | Antispasmodic | 1 (1.3) | 1 (0.9) |
| Oral rehydration salt | Mineral supplement | 1 (1.3) | 1 (0.9) |
| (Diphenoxylate HCL 2.5 + Atropine Sulphate 0.025mg) + Domperidone 10mg | Antidiarrheal + Antidopaminergic/Antiemetic | 1 (1.3) | 2 (1.6) |
| Metronidazole 200mg + Paracetamol | Antimicrobial + Antipyretic | 1 (1.3) | 2 (1.6) |
| Metronidazole 200mg + Paracetamol+ Hyoscine-N-ButylBromide 10mg | Antimicrobial + Antipyretic + Antispasmodic | 1 (1.3) | 3 (2.4) |
| Loperamide 2mg + Paracetamol + Domperidone 10mg | Antimotility + Antipyretic + Antidopaminergic/Antiemetic | 1 (1.3) | 3 (2.4) |
| (Diphenoxylate HCL 2.5 + Atropine Sulphate 0.025mg) + Domperidone 10mg + Hyoscine-N-ButylBromide 10mg | Antidiarrheal + Antidopaminergic/Antiemetic + Antispasmodic | 1 (1.3) | 3 (2.4) |
| (Diphenoxylate HCL 2.5 + Atropine Sulphate 0.025mg) + Hyoscine-N-ButylBromide 10mg + Paracetamol | Antidiarrheal + Antispasmodic + Antipyretic | 1 (1.3) | 3 (2.4) |
| Total | 75 (100) | 122 (100) |